Opexa Therapeutics, Inc. of THE WOODLANDS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-05. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Biotechnology.
Showing 25 of 37 people.
| Name | Role | Location |
|---|---|---|
| Jason M Amello | Director | Newton, MA |
| Stephen T Aselage | Director | Newton, MA |
| John M Dunn | Director | Newton, MA |
| Michelle T Griffin | Director | Newton, MA |
| Chris Schelling | Director | Newton, MA |
| Jefferson E Davis | Executive Officer | Newton, MA |
| Tanya T Hayden | Executive Officer | Newton, MA |
| John M Klopp | Executive Officer | Newton, MA |
| Bernie S Paul | Executive Officer | Newton, MA |
| Adrian S Quartel | Executive Officer | Newton, MA |
| Chris Schelling | Executive Officer | Newton, MA |
| Matthew T Seibt | Executive Officer | Newton, MA |
| Neil K Warma | Director | Toronto, A6 |
| Neil K Warma | Executive Officer | Toronto, A6 |
| Matthew S Seibt | Executive Officer | Newton, MA |
| Michelle Griffin | Director | Newton, MA |
| John S Klopp | Executive Officer | Newton, MA |
| Harry S Palmin | Executive Officer | Newton, MA |
| Donald R Joseph | Executive Officer | Newton, MA |
| Stephen Aselage | Director | Newton, MA |
| Michael S Richman | Director | Boston, MA |
| DAVID E JORDEN | Director | GAITHERSBURG, MD |
| DAVID E JORDEN | Executive Officer | GAITHERSBURG, MD |
| Gail J Maderis | Director | Emeryville, CA |
| DAVID HUNG | Director | ALAJUELA, G2 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2020-07-29 | D | $857K | $857K |
| 2013-02-19 | D | $650K | $650K |
| 2013-02-19 | D | — | — |
| 2012-11-19 | D | $15.0M | — |
| 2012-07-27 | D | $4.1M | $4.1M |
| 2009-04-27 | D | $2.0M | $1.1M |